Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.33 |
| ▸ | GALR3 | O60755 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2540758 | 0.82 | TSHR (0.50) | TSHRALDH1A1THRBCHRM2CHRM4 | |
| SCHEMBL2544205 | 0.82 | TSHR (0.50) | TSHRALDH1A1THRBCHRM2CHRM4 | |
| SCHEMBL1130699 | 0.80 | TSHR (0.43) | TSHRALDH1A1THRBHSD17B10TDP1 | |
| SCHEMBL15751663 | 0.80 | TSHR (0.48) | TSHRALDH1A1THRBCHRM2CHRM4 | |
| SCHEMBL2013862 | 0.80 | TSHR (0.54) | TSHRALDH1A1THRBCHRM2CHRM4 | |
| SCHEMBL377956 | 0.80 | TSHR (0.48) | TSHRALDH1A1THRBCHRM2CHRM4 | |
| SCHEMBL33467 | 0.80 | TSHR (0.48) | TSHRALDH1A1THRBCHRM2CHRM4 | |
| SCHEMBL204713 | 0.80 | TSHR (0.48) | TSHRALDH1A1THRBCHRM2CHRM4 | |
| SCHEMBL15318827 | 0.80 | TSHR (0.48) | TSHRALDH1A1THRBCHRM2CHRM4 | |
| SCHEMBL1951992 | 0.78 | TSHR (0.42) | TSHRALDH1A1THRBHSD17B10TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8586020-B2 | Poly(organophosphazene) composition for biomaterials | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2013-11-19 | — | — | US | disclosed |
| US-20130004455-A1 | POLY(ORGANOPHOSPHAZENE) COMPOSITION FOR BIOMATERIALS | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2013-01-03 | — | — | US | disclosed |
| EP-2540764-A2 | Poly(organophosphazene) composition for biomaterials | Korea Institute of Science and Technology (KR) | 2013-01-02 | — | — | EP | disclosed |
| US-8313771-B2 | Phosphazene hydrogels with chemical corss-link, preparation method thereof and use thereof | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2012-11-20 | — | — | US | disclosed |
| EP-1798252-B1 | CROSSLINKED FLUOROCOPOLYMER MOLDINGS | UNIMATEC CO LTD (JP) | 2009-10-21 | — | — | EP | disclosed |
| US-20090023863-A1 | CROSS-LINKED FLUORINE-CONTAINING COPOLYMER MOLDINGS | UNIMATEC CO., LTD. (JP) | 2009-01-22 | — | — | US | disclosed |
| EP-1798252-A1 | CROSSLINKED FLUOROCOPOLYMER MOLDINGS | Unimatec Co., Ltd. (JP) | 2007-06-20 | — | — | EP | disclosed |
| EP-0421435-B1 | Ultrathin membrane of polymethacrylate or polycrotonate and device provided with ultrathin membrane | NIPPON OILS & FATS CO LTD (JP) | 1996-01-10 | — | — | EP | disclosed |
| US-5209847-A | ULTRATHIN MEMBRANE OF POLYMETHACRYLATE OR POLYCROTONATE AND DEVICE PROVIDED WITH ULTRATHIN MEMBRANE | NIPPON OIL AND FATS CO., LTD. (JP) | 1993-05-11 | — | — | US | disclosed |
| EP-0421435-A2 | Ultrathin membrane of polymethacrylate or polycrotonate and device provided with ultrathin membrane | NIPPON OIL AND FATS COMPANY, LIMITED (JP) | 1991-04-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130004455-A1 | POLY(ORGANOPHOSPHAZENE) COMPOSITION FOR BIOMATERIALS | PHOSPHO1, PGLS, PHYKPL | TSHR 4580/4885ALDH1A1 2323/4885MAPK1 3654/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.